rs56175056

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2

The NM_000744.7(CHRNA4):​c.1006C>T​(p.Arg336Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000732 in 1,613,796 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R336H) has been classified as Benign.

Frequency

Genomes: 𝑓 0.00041 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00076 ( 1 hom. )

Consequence

CHRNA4
NM_000744.7 missense

Scores

3
11
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:5

Conservation

PhyloP100: 2.29
Variant links:
Genes affected
CHRNA4 (HGNC:1958): (cholinergic receptor nicotinic alpha 4 subunit) This gene encodes a nicotinic acetylcholine receptor, which belongs to a superfamily of ligand-gated ion channels that play a role in fast signal transmission at synapses. These pentameric receptors can bind acetylcholine, which causes an extensive change in conformation that leads to the opening of an ion-conducting channel across the plasma membrane. This protein is an integral membrane receptor subunit that can interact with either nAChR beta-2 or nAChR beta-4 to form a functional receptor. Mutations in this gene cause nocturnal frontal lobe epilepsy type 1. Polymorphisms in this gene that provide protection against nicotine addiction have been described. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP6
Variant 20-63350405-G-A is Benign according to our data. Variant chr20-63350405-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 205020.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=2, Likely_benign=5}. Variant chr20-63350405-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000414 (63/152220) while in subpopulation NFE AF= 0.000691 (47/68034). AF 95% confidence interval is 0.000534. There are 0 homozygotes in gnomad4. There are 28 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 63 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CHRNA4NM_000744.7 linkuse as main transcriptc.1006C>T p.Arg336Cys missense_variant 5/6 ENST00000370263.9
CHRNA4NM_001256573.2 linkuse as main transcriptc.478C>T p.Arg160Cys missense_variant 5/6
CHRNA4NR_046317.2 linkuse as main transcriptn.1215C>T non_coding_transcript_exon_variant 5/6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CHRNA4ENST00000370263.9 linkuse as main transcriptc.1006C>T p.Arg336Cys missense_variant 5/61 NM_000744.7 P1P43681-1

Frequencies

GnomAD3 genomes
AF:
0.000414
AC:
63
AN:
152220
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000691
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000331
AC:
83
AN:
250798
Hom.:
0
AF XY:
0.000309
AC XY:
42
AN XY:
135826
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000689
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000765
AC:
1118
AN:
1461576
Hom.:
1
Cov.:
99
AF XY:
0.000718
AC XY:
522
AN XY:
727082
show subpopulations
Gnomad4 AFR exome
AF:
0.000358
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000908
Gnomad4 OTH exome
AF:
0.00154
GnomAD4 genome
AF:
0.000414
AC:
63
AN:
152220
Hom.:
0
Cov.:
32
AF XY:
0.000376
AC XY:
28
AN XY:
74372
show subpopulations
Gnomad4 AFR
AF:
0.000362
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000691
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000572
Hom.:
0
Bravo
AF:
0.000457
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00156
AC:
6
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.000930
AC:
8
ExAC
AF:
0.000264
AC:
32
EpiCase
AF:
0.000927
EpiControl
AF:
0.000771

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jan 16, 2017- -
Likely benign, criteria provided, single submitterclinical testingGeneDxJan 14, 2021This variant is associated with the following publications: (PMID: 24385388, 19058950, 26440539, 26952864) -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenSep 01, 2022CHRNA4: BS1:Supporting -
Autosomal dominant nocturnal frontal lobe epilepsy 1 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingRevvity Omics, RevvityAug 26, 2022- -
Autosomal dominant nocturnal frontal lobe epilepsy Benign:1
Likely benign, criteria provided, single submitterclinical testingInvitaeJan 07, 2024- -
CHRNA4-related disorder Benign:1
Likely benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesNov 14, 2023This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsJan 29, 2019This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Uncertain
-0.060
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.68
D;.
Eigen
Uncertain
0.30
Eigen_PC
Uncertain
0.27
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.97
D;D
M_CAP
Pathogenic
0.37
D
MetaRNN
Uncertain
0.64
D;D
MetaSVM
Uncertain
0.57
D
MutationAssessor
Pathogenic
3.0
M;.
MutationTaster
Benign
1.0
D
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-2.3
N;.
REVEL
Uncertain
0.54
Sift
Benign
0.031
D;.
Sift4G
Uncertain
0.027
D;D
Polyphen
0.85
P;.
Vest4
0.61
MVP
0.96
MPC
1.4
ClinPred
0.61
D
GERP RS
4.2
Varity_R
0.17
gMVP
0.53

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs56175056; hg19: chr20-61981757; COSMIC: COSV64718620; COSMIC: COSV64718620; API